Related Experiment Videos
The Fourth International Conference on Malignant Lymphoma
1Department of Medicine, University of Chicago, Illinois.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Clinical cancer research : an official journal of the American Association for Cancer Research·1998
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·1998
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Advances in γδ T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms.
The Journal of dermatology·2026
Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.
Apoptosis : an international journal on programmed cell death·2026
Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.
Frontiers in oncology·2026
Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.
Nature reviews. Cancer·2026
Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.
Clinical rheumatology·2026